The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia

被引:61
作者
Brailo, V
Vucicevic-Boras, V
Cekic-Arambasin, A
Alajbeg, IZ
Milenovic, A
Lukac, J
机构
[1] Univ Zagreb, Sch Dent Med, Dept Oral Med, Zagreb 10000, Croatia
[2] Univ Zagreb, Sch Dent Med, Dept Prosthodont, Zagreb 10000, Croatia
[3] Univ Zagreb, Clin Hosp Dubrava, Clin Maxillofacial Surg, Zagreb 10000, Croatia
[4] Univ Zagreb, Clin Hosp Sestre Milosrdnice, Clin Nucl Med & Oncol, Zagreb, Croatia
关键词
leukoplakia; interteukin; 6; tumor necrosis; factor alpha; saliva;
D O I
10.1016/j.oraloncology.2005.09.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
It is well known that cytokines play an important role in oral diseases. Furthermore, increased levels of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) have been reported in patients with cancer and premalignant lesions such as oral lichen planus and oral submucous fibrosis. The aim of this study was to assess salivary IL-6 and TNF-alpha Levels in 30 patients with histopathologically confirmed leukoplakia (age range 24-78, mean 52.3 years) in comparison to 34 controls (age range 27-79, mean 52 years). Salivary IL-6 and TNF-alpha were determined by enzyme linked immunoadsorbent assay. Statistical analysis was performed by use of Mann-Whitney test for independent samples and values lower than 0.05 were considered as significant (p < 0.05). Significantly higher levels of salivary IL-6 and TNF-alpha in patients with oral leukoplakia when compared to healthy controls were found. The levels of salivary IL-6 and TNF-alpha did not correlate with the size of leukoplakia (lesions) nor with its localization regarding high and tow risk sites for malignant transformation. Levels of salivary IL-6 and TNF-alpha were not influenced by smoking habits. We can conclude that increased salivary IL-6 and TNF-alpha might play a certain role in oral leukoplakia. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 373
页数:4
相关论文
共 24 条
[1]
[Anonymous], 1997, ORAL HLTH SURVEYS BA, V4th
[2]
Oral white lesions with special reference to precancerous and tobacco related lesions: Conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994 [J].
Axell, T ;
Pindborg, JJ ;
Smith, CJ ;
vanderWaal, I .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1996, 25 (02) :49-54
[3]
Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease [J].
Boström, L ;
Linder, LE ;
Bergström, J .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1999, 26 (06) :352-357
[4]
The association between inflammation markers, coronary artery disease and smoking [J].
de Maat, MPM ;
Kluft, C .
VASCULAR PHARMACOLOGY, 2002, 39 (03) :137-139
[5]
Dong G, 1999, CANCER RES, V59, P3495
[6]
Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-α in patients with chronic periodontitis [J].
Erdemir, EO ;
Duran, I ;
Haliloglu, S .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2004, 31 (02) :99-104
[7]
Oral submucous fibrosis patients have altered levels of cytokine production [J].
Haque, MF ;
Meghji, S ;
Khitab, U ;
Harris, M .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (03) :123-128
[8]
Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation [J].
Hodge, DR ;
Peng, B ;
Cherry, JC ;
Hurt, EM ;
Fox, SD ;
Kelley, JA ;
Munroe, DJ ;
Farrar, WL .
CANCER RESEARCH, 2005, 65 (11) :4673-4682
[9]
Jablonska Ewa, 1997, Pathol Oncol Res, V3, P126
[10]
PROSTAGLANDIN-E2 AND INTERLEUKIN-1 LEVELS IN SMOKELESS TOBACCO-INDUCED ORAL MUCOSAL LESIONS [J].
JOHNSON, GK ;
POORE, TK ;
SQUIER, CA ;
WERTZ, PW ;
REINHARDT, RA ;
VINCENT, SD .
JOURNAL OF PERIODONTAL RESEARCH, 1994, 29 (06) :430-438